Pandemic surge causes major shortage of a drug for severe Covid-19 and rheumatoid arthritis

"This is not the first shortage in the pandemic. Supply chains were disrupted when factories had to shut down to prevent the spread of the virus, and Covid-19 put a real demand shock on top of a system that was already fragile, according to Erin Fox, an expert on drug shortages who works as a senior director, drug information and support services at University of Utah Health."